<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0059">
 <label>59</label>
 <mixed-citation publication-type="web">
  <person-group person-group-type="author">
   <string-name>
    <surname>Rossi</surname>
    <given-names>GP.</given-names>
   </string-name>
  </person-group> Randomized clinical trial in COVID19 patients to assess the efficacy of the transmembrane protease serine 2 (TMPRSS2) inhibitor nafamostat (RACONA study). University Hospital Padova, Italy. 
  <year>2020</year>. Available from: 
  <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04352400" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/ct2/show/NCT04352400</ext-link>.
 </mixed-citation>
</ref>
